Standard BioTools reported earnings of $ 0.03 per LAB share on Nov 3, 2026, falling short of analysts' expectations by
| Report Date | Nov 3, 2026 |
|---|---|
| Forecasted EPS | -$ 0.02 |
| Earnings Per Share (Surprise) | $ 0.03 (+$ 0.05) |
| Last Year's EPS | -$ 0.01 |
| EPS YoY Change |
Out of the last 82 earnings reporting periods, Standard BioTools beat analysts’ expectations 34 times and fell short of expectations 33 time(s). Standard BioTools reported earnings per share of $ 0.03 in the last report surpassing an estimated EPS of -$ 0.02 by
| Report Date | Forecasted EPS | Reported EPS | Last Year's EPS | EPS YoY Change |
|---|---|---|---|---|
| Nov 3, 2026 | -$ 0.02 | $ 0.03 | $ 0.05 | |
| Aug 5, 2026 | -$ 0.01 | -$ 0.07 | $ 0.06 | |
| May 6, 2026 | - | $ 0.33 | -$ 0.09 | |
| May 5, 2026 | -$ 0.02 | -$ 0.02 | -$ 0.04 | |
| Mar 16, 2026 | - | $ 0.05 | -$ 0.04 | |
| Feb 24, 2026 | -$ 0.03 | $ 0.06 | -$ 0.05 | |
| Nov 4, 2025 | -$ 0.04 | -$ 0.09 | -$ 0.05 | |
| Aug 11, 2025 | -$ 0.04 | -$ 0.04 | -$ 0.08 | |
| May 6, 2025 | -$ 0.04 | -$ 0.04 | -$ 0.27 | |
| Feb 26, 2025 | -$ 0.07 | -$ 0.05 | -$ 0.25 | |
| Oct 30, 2024 | -$ 0.08 | -$ 0.05 | -$ 0.27 | |
| Jul 31, 2024 | -$ 0.06 | -$ 0.08 | -$ 0.22 | |
| May 8, 2024 | -$ 0.12 | -$ 0.27 | -$ 0.21 | |
| Feb 28, 2024 | -$ 0.13 | -$ 0.25 | -$ 0.26 | |
| Nov 7, 2023 | -$ 0.23 | -$ 0.27 | -$ 0.37 | |
| Aug 8, 2023 | -$ 0.21 | -$ 0.22 | -$ 0.82 | |
| May 9, 2023 | -$ 0.06 | -$ 0.21 | -$ 0.99 | |
| Feb 14, 2023 | -$ 0.11 | -$ 0.26 | -$ 0.99 | |
| Nov 8, 2022 | -$ 0.13 | -$ 0.37 | -$ 0.12 | |
| Aug 8, 2022 | -$ 0.13 | -$ 0.82 | -$ 0.18 |
Standard BioTools’s stock was trading at $ 0.6099 on Nov 2, 2026 a day before the last earnings report was released.Following the release of the earnings report, LAB’s price increased to $ 0.616 on Nov 4, 2026, recording a
| Report Date | EPS | Price 1 Day Before | Price 1 Day After | Change |
|---|---|---|---|---|
| Nov 3, 2026 | $ 0.03 | $ 0.6099 | $ 0.616 | |
| Aug 5, 2026 | -$ 0.07 | $ 0.8205 | $ 0.8001 | |
| May 6, 2026 | $ 0.33 | $ 0.979 | $ 1.00 | |
| May 5, 2026 | -$ 0.02 | $ 0.935 | $ 0.9685 | |
| Mar 16, 2026 | $ 0.05 | $ 0.9326 | $ 0.9837 | |
| Feb 24, 2026 | $ 0.06 | $ 1.11 | $ 1.17 | |
| Nov 4, 2025 | -$ 0.09 | $ 1.24 | $ 1.14 | |
| Aug 11, 2025 | -$ 0.04 | $ 1.31 | $ 1.31 | |
| May 6, 2025 | -$ 0.04 | $ 1.15 | $ 1.02 | |
| Feb 26, 2025 | -$ 0.05 | $ 1.26 | $ 1.05 | |
| Oct 30, 2024 | -$ 0.05 | $ 1.75 | $ 1.96 | |
| Jul 31, 2024 | -$ 0.08 | $ 2.32 | $ 1.42 | |
| May 8, 2024 | -$ 0.27 | $ 2.37 | $ 2.41 | |
| Feb 28, 2024 | -$ 0.25 | $ 2.34 | $ 2.25 | |
| Nov 7, 2023 | -$ 0.27 | $ 2.04 | $ 1.90 | |
| Aug 8, 2023 | -$ 0.22 | $ 2.40 | $ 2.56 | |
| May 9, 2023 | -$ 0.21 | $ 1.65 | $ 1.80 | |
| Feb 14, 2023 | -$ 0.26 | $ 2.10 | $ 2.10 | |
| Nov 8, 2022 | -$ 0.37 | $ 1.01 | $ 0.9335 | |
| Aug 8, 2022 | -$ 0.82 | $ 1.89 | $ 1.68 |
Standard BioTools released its most recent earnings reports in November 2026, August 2026, May 2026, May 2026 respectively. Generally, most companies have a consistent schedule for their earnings releases. However, companies do not necessarily release their earnings reports at the same time each year. The timing of earnings releases can vary depending on a company's fiscal year, industry norms, and internal reporting practices.
Standard BioTools beat analysts’ expectations during the last earnings period by
